Sentence examples for booster table from inspiring English sources

Similarly, seroprotection rates assessed by SRH increased from 18% (18 60 years) and 21% (>60 years) immediately before the 7.5 μg booster to 89% and 84%, respectively, 3 weeks following the booster (Table 3).

MN titers in non-elderly and elderly recipients increased from 41% to 94% and from 42% to 97%, respectively, after the 7.5 μg booster and from 53% to 96% and from 69% to 96%, respectively, after the 15 μg booster (Table 4).

Seropositivity rates ranged from 95.9 100% against all the MMRV antigens one month post-booster (Table 4).

However, protection was increased to levels comparable to that seen with Schu S4 ΔpurMCD and wild-type LVS following administration of a booster immunization (Table 2, rows 13 16).

Very few subjects required medical advice for solicited symptoms following either primary or booster doses (Table 2).

More refusers than consenters had concerns about vaccine safety in general, side effects and booster doses (Table 3).

The two treatment groups were comparable in terms of age, body mass index (BMI) and time since last booster vaccination (Table 1).

The percentages of children with PC frequencies below the detection limit, variable between groups and serotypes, declined after the booster (Supplementary Table 3).

Nine of the 10 vaccinated birds mounted homologous H5-specific antibodies 3 weeks after the first vaccination; titers increased significantly after the booster vaccination (Table 1).

Percentages with an OPA titer ≥8 for cross-reactive serotypes 6A and 19A were in the same ranges as those in the PHiD-CV booster group (Table 3).

The percentage of subjects with seroprotective anti-PRP antibody concentrations was between 87.0% and 95.5% after dose 2, increasing to between 98.2% and 100% after the booster dose (Table 2).